Subclinical hypothyroidism. Subclinical iodine-deficiency hypothyroidism
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Hypothyroid patients who are diagnosed with endocrinologist and with 10> TSH>2 age beween 16 and 65 years Written consent of the patient to participate in the study Lack of heart disease, coagulation disorders, autoimmune disorders No pituitary and hypothalamic problems, kidney disease, malignancy and other thyroid disorders No pregnancy or breastfeeding
Exclusion criteria
Exclusion criteria: Taking herbal supplements not attending regular exercise
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gp91 phox. Timepoint: Beginning and end of the study after 8 weeks. Method of measurement: ELISA.;Hs-CRP. Timepoint: Beginning and end of the study after 8 weeks. Method of measurement: ELISA.;FABP4. Timepoint: Beginning and end of the study after 8 weeks. Method of measurement: ELISA.;Adrenomedullin. Timepoint: Beginning and end of the study after 8 weeks. Method of measurement: ELISA. | — |
Secondary
| Measure | Time frame |
|---|---|
| Lipid profiles. Timepoint: Beginning and end of 8 weeks. Method of measurement: Enzymatic method.;Thyroid hormones. Timepoint: Beginning and end of 8 weeks. Method of measurement: Thyroid hormones, including thyroid stimulating hormone, triiodothyronine and thyroxine, will be measured by ELISA.;Body composition. Timepoint: Beginning and end of 8 weeks. Method of measurement: Body composition will be measured by bioimpedance (BIA). | — |
Countries
Iran (Islamic Republic of)
Contacts
University of Sistan and Baluchestan